Telehealth: “Should I Stay or Should I Go...?”
Christina Farr
15 min read
A deep dive on the latest trends in federal lobbying activity and legislative reform in the US
All Articles
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
Who are the most active early-stage investors in digital health?
Christina Farr
21 min read
We compiled a short-list so you don't have to
Who are Europe's most active Health-tech investors?
Christina Farr
14 min read
We compiled a list so you don't have to
Hiring? These top recruiters have a lot of wisdom to share with health-tech founders
Christina Farr
10 min read
Top talent may have different priorities than you might expect...
In defense of tech-enabled services
Christina Farr
13 min read
Why we remain bullish on services, even as the market has shifted to favor software
The rules, laws, and policy digital health needs to know to stay ahead this year
Christina Farr
35 min read
We broke it down so you don't have to
I asked a bunch of health-tech experts for their not boring '23 predictions
Christina Farr
10 min read
Don't worry, you can hold us all accountable next year...
The impending overhaul of the US organ transplant system
Christina Farr
9 min read
A call to action for health tech builders
Meet the nurse who's also a private equity investor
Christina Farr
8 min read
Meghan Fitzgerald's investment thesis is grounded in her experiences across pharmacy, pharma and health systems - as well as countless hours spent in the ICU.
'To do Thought Leadership effectively, you first need to have thoughts'
Christina Farr
10 min read
A guide to getting storytelling right from former PillPack Head of Communications Jacqui Miller
This new class of weight loss drugs are costly - but is there a greater price to ignoring the problem?
Christina Farr
11 min read
Obesity is a complex chronic disease - and it's time we treated it as such.
Why the fertility market is poised to explode
Christina Farr
22 min read
Our deep dive into the space including analysis, predictions, a market map and interviews with a wide range of experts.